Opinion|Videos|January 12, 2026
Comparing Safety Profiles and Health Care Costs
Panelists discuss how optimizing safety and cost-efficiency are central to improving adherence and overall health care value.
Advertisement
Episodes in this series
Panelists discuss how safety profiles significantly impact both clinical outcomes and economic sustainability in schizophrenia management. Drugs with fewer adverse effects tend to improve adherence and lower hospital readmissions.
Panelists discuss how second-generation and novel agents generally offer better metabolic and neurologic safety, which can translate into reduced long-term health care spending.
Panelists discuss how evaluating total cost of care rather than upfront medication cost ensures more rational treatment decisions and sustainable systemwide outcomes.
Advertisement
Related to this article
Merck has begun the phase 3 ENHANCE-3 trial testing whether ensifentrine added to standard of care prevents COPD exacerbations in high-risk adults.
Non-CF bronchiectasis prevalence rose across commercial, Medicare, and Medicaid plans from 2016 to 2024, while incidence stayed relatively stable.
Shorter telomere length was linked to a usual interstitial pneumonia pattern (UIP) on CT in patients with ILD, per research presented at CHEST 2026.
Low awareness that fatty liver can silently progress and that MASH fibrosis is treatable drives missed follow-up testing, says Rohit Loomba, MD.
The FDA approved asundexian (Sunharbo) with antiplatelet therapy to reduce recurrent stroke risk after noncardioembolic stroke or high-risk TIA.
The FDA granted accelerated approval to amivantamab and hyaluronidase for previously treated recurrent or metastatic head and neck cancer.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
3
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5